Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients
Open Access
- 4 December 2021
- journal article
- research article
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 15 (1) , 51-55
Abstract
No abstract availableKeywords
Funding Information
- King Faisal Specialist Hospital and Research Centre (2200009)
This publication has 16 references indexed in Scilit:
- Immunogenicity of SARS‐CoV‐2 mRNA vaccine in solid organ transplant recipientsJournal of Internal Medicine, 2021
- Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2Nature, 2021
- Severe consequences of COVID-19 infection among vaccinated kidney transplant recipientsAmerican Journal of Transplantation, 2021
- Immune response to SARS-CoV-2 variants of concern in vaccinated individualsNature Communications, 2021
- Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological studyThe Lancet Public Health, 2021
- Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipientsAmerican Journal of Transplantation, 2021
- Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7Nature, 2021
- Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort StudyClinical Infectious Diseases, 2020
- Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)Clinical Infectious Diseases, 2020
- Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2Viruses, 2020